SCHEMBL6537417

SCHEMBL6537417

Cc1nccn1-c1c(Br)cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 5/20 0.40
JAK2 O60674 3/20 0.40
JAK1 P23458 3/20 0.40
CYP3A4 P08684 4/20 0.39
CYP2D6 P10635 3/20 0.39
KCNH2 Q12809 2/20 0.39
GPR142 Q7Z601 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ITGB1 P05556 1/20 0.38
ITGA4 P13612 1/20 0.38
ITGB7 P26010 1/20 0.38
CACNA1C Q13936 1/20 0.37
SCN5A Q14524 1/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538367 0.87 CYP3A4 (0.40) TYK2JAK2JAK1CYP3A4CYP2D6
SCHEMBL6537346 0.83 CYP3A4 (0.47) TYK2JAK2JAK1CYP3A4CYP2D6
SCHEMBL6538268 0.82 TYK2 (0.45) TYK2JAK2JAK1CYP3A4CYP2D6
SCHEMBL6537933 0.81 TYK2 (0.44) TYK2JAK2JAK1CYP3A4HTT
SCHEMBL6537579 0.79 MAPK10 (0.51) HTTSMN1; SMN2TSHRLMNAMEN1
SCHEMBL6537962 0.79 TYK2 (0.46) TYK2JAK2JAK1CYP3A4HTT
SCHEMBL8474859 0.77 CYP3A4 (0.52) TYK2JAK2JAK1CYP3A4CYP2D6
SCHEMBL6537722 0.76 KMT2A (0.43) TYK2JAK2JAK1CYP3A4CYP2D6
SCHEMBL6537504 0.75 CYP3A4 (0.47) TYK2JAK2JAK1CYP3A4CYP2D6
SCHEMBL6537345 0.75 TYK2 (0.47) TYK2JAK2JAK1CYP3A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed